down arrow

China National Accord Medicines Corp. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE0000009N6
  • SHE: 000028
CNY
19.90
-0.13 (-0.65%)

Sep 22

SHE

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
China National Accord Medicines Corp. Ltd.

Why is China National Accord Medicines Corp. Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 3.02% and Operating profit at -4.12% over the last 5 years
2
Flat results in Mar 26
  • OPERATING CASH FLOW(Y) Lowest at CNY 620.2 MM
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,011.46
  • INVENTORY TURNOVER RATIO(HY) Lowest at 7.9 times
3
With ROE of 6.01%, it has a very attractive valuation with a 0.57 Price to Book Value
  • Over the past year, while the stock has generated a return of -10.59%, its profits have risen by 609.3% ; the PEG ratio of the company is 0
  • At the current price, the company has a high dividend yield of 1.7
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -10.59% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to China National Accord Medicines Corp. Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is China National Accord Medicines Corp. Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
China National Accord Medicines Corp. Ltd.
-14.16%
-1.98
23.51%
China Shanghai Composite
3.23%
1.20
14.07%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.02%
EBIT Growth (5y)
-4.12%
EBIT to Interest (avg)
7.22
Debt to EBITDA (avg)
2.09
Net Debt to Equity (avg)
0.36
Sales to Capital Employed (avg)
2.40
Tax Ratio
31.13%
Dividend Payout Ratio
27.44%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.48%
ROE (avg)
9.30%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.58
EV to EBIT
11.19
EV to EBITDA
6.88
EV to Capital Employed
0.70
EV to Sales
0.25
PEG Ratio
0.02
Dividend Yield
2.51%
ROCE (Latest)
6.22%
ROE (Latest)
6.01%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
INTEREST COVERAGE RATIO(Q)

Highest at 2,123.63

NET PROFIT(9M)

Higher at CNY 842.6 MM

DEBT-EQUITY RATIO (HY)

Lowest at 34.61 %

PRE-TAX PROFIT(Q)

Highest at CNY 403.35 MM

-6What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 192.16 MM

INTEREST(Q)

At CNY 36.85 MM has Grown at 10.58%

RAW MATERIAL COST(Y)

Grown by 7.19% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.87 times

Here's what is working for China National Accord Medicines Corp. Ltd.

Net Profit
At CNY 842.6 MM has Grown at 215.95%
Year on Year (YoY)
MOJO Watch
Net Profit trend is very positive

Net Profit (CNY MM)

Interest Coverage Ratio
Highest at 2,123.63
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Pre-Tax Profit
Highest at CNY 403.35 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Debt-Equity Ratio
Lowest at 34.61 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Profit
Higher at CNY 842.6 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (CNY MM)

Here's what is not working for China National Accord Medicines Corp. Ltd.

Interest
At CNY 36.85 MM has Grown at 10.58%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Operating Cash Flow
Lowest at CNY 192.16 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Debtors Turnover Ratio
Lowest at 2.87 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost
Grown by 7.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading